Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine

Tan Wu1, Xiaoyue Xu1, Dan Xu2

  • 1Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center For Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.

Insights

This study introduces a novel nanocatalytic therapy using engineered metal-organic framework nanomedicine (MAL) to amplify cancer cell apoptosis. MAL effectively triggers DNA damage and cell cycle disruption, inhibiting tumor growth with good biocompatibility.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Nanocatalytic therapy offers localized cancer treatment by converting substrates into cytotoxic agents.
  • Current limitations include a lack of durable, DNA-targeting cytotoxic mechanisms.
  • Enhanced apoptosis induction is crucial for effective cancer cell killing.

Purpose of the Study:

  • To develop a cascade nanocatalysis strategy for amplifying endogenous apoptosis in cancer cells.
  • To engineer a metal-organic framework nanomedicine (MOF-Au-L-Arginine, MAL) for this purpose.
  • To investigate MAL's mechanism of action and in vivo efficacy.

Main Methods:

  • Fabrication of MOF-Au-L-Arginine nanomedicine (MAL).
  • In vitro analysis of reactive oxygen species generation, DNA damage, cell cycle arrest, and apoptosis.
  • Genome-wide RNA sequencing to identify pathway activation (e.g., p53).
  • In vivo studies to evaluate tumor inhibition and biocompatibility.

Main Results:

  • MAL effectively catalyzes the generation of hydroxyl radicals and superoxide anions, leading to peroxynitrite formation.
  • Peroxynitrite induces significant DNA damage, impairs DNA repair, and disrupts the cell cycle.
  • MAL activates the p53 pathway and promotes mitochondrial-mediated apoptosis via the BAX/Bcl-2/caspase-3 axis.
  • In vivo studies demonstrated effective tumor growth inhibition with favorable biocompatibility.

Conclusions:

  • The developed cascade nanocatalysis strategy effectively amplifies endogenous apoptosis for cancer therapy.
  • MAL shows potential as a next-generation nanocatalytic therapeutic agent with enhanced efficacy and reduced toxicity.
  • Further research into MAL's therapeutic applications is warranted.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
3.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.6K